Cape Verde vs Vanuatu: New cases tested for RR-/MDR-TB
Cape Verde
4.3%
in 2024
Vanuatu
3.8%
in 2024
Cape Verde rank
180th
Vanuatu rank
181st
New cases tested for RR-/MDR-TB over time
- Cape Verde
- Vanuatu
How they compare
Cape Verde currently reports 4.3% against 3.8% in Vanuatu, a difference of 0.5%.
That makes Cape Verde's figure about 1.1 times Vanuatu's.
The two have swapped places 7 times across 14 shared years of data; in 2009 it was Vanuatu ahead.
Cape Verde ranks 180th and Vanuatu ranks 181st of 192 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and Vanuatu in 1.
Head to head by decade
| Decade | Cape Verde | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 25.8% | 37.3% | 11.5% | Vanuatu |
| 2020s | 43.9% | 39.4% | 4.5% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Cape Verde or Vanuatu?
- Cape Verde, at 4.3% against 3.8% in Vanuatu as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Cape Verde and Vanuatu?
- 0.5%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Vanuatu?
- 14 years are reported by both, from 2009 to 2024.
- How do Cape Verde and Vanuatu rank globally for new cases tested for rr-/mdr-tb?
- Cape Verde ranks 180th and Vanuatu ranks 181st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.